Moreover, aside from pro-angiogenic function, CSF2 is increasingly recognized to exacerbate tumor progression by its cytokine-mediated immunosuppressive effects on various surrounding cells in tumor microenvironments 48, hence leading to sheer reliance on CSF2 for tumor growth in several solid cancers with adverse prognostic impact. This evidence concerns the gene CSF2 and neoplasm.